文献速递神经肿瘤功能神经外科

脑肿瘤治疗中记忆恢复与默认模式网络损伤及神经突密度相关

Memory recovery in relation to default mode network impairment and neurite density during brain tumor treatment.
PubMed 文献 · J Neurosurg · 2021-08-06

采用NODDI和静息态网络分析发现,术前肿瘤及术后病灶与默认模式网络重叠负向关联记忆恢复,而默认模式网络内高神经突密度正向关联记忆恢复。

要点

  • 术前肿瘤与默认模式网络重叠负向关联记忆恢复(Pfdr=0.002)。
  • 默认模式网络内术前高神经突密度正向关联记忆恢复(Pfdr<10-3)。
  • 传统脑叶分类的肿瘤位置与记忆恢复无显著关联。

核心结论

  • NODDI和静息态网络可识别认知恢复与下降的影像生物标志物。
  • 影响默认模式网络等记忆功能关键网络的脑肿瘤及其治疗可显著影响记忆恢复。

研究设计与样本

  • 术前、术后及12个月恢复期共进行47次MRI扫描(排除后),每次扫描后行平板电脑记忆测试。
  • 采用线性混合效应模型回归年龄、性别、肿瘤分级、治疗类型、总病灶体积和总神经突密度的影响。

主要发现

  • 肿瘤非局部效应明显:神经突密度降低不仅见于肿瘤内,也延伸至肿瘤边界外。
  • 术前肿瘤与默认模式网络重叠负向关联记忆恢复(LMM,Pfdr=0.002)。
  • 术后病灶与默认模式网络重叠负向关联记忆恢复(LMM,Pfdr<10-4)。
  • 术前肿瘤外但默认模式网络内高神经突密度正向关联记忆恢复(LMM,Pfdr<10-3)。
  • 术后及随访时默认模式网络和额顶网络内神经突密度正向关联记忆恢复(LMM,Pfdr=0.014和Pfdr=0.001)。

临床怎么用

  • 可利用NODDI和静息态网络评估脑肿瘤患者记忆恢复的影像生物标志物。
  • 默认模式网络内神经突密度和病灶重叠情况有助于识别记忆恢复风险。

局限性

  • 仅纳入弥漫性非强化胶质瘤患者,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to test brain tumor interactions with brain networks, thereby identifying protective features and risk factors for memory recovery after resection. METHODS: Seventeen patients with diffuse nonenhancing glioma (ages 22-56 years) underwent longitudinal MRI before and after surgery, and during a 12-month recovery period (47 MRI scans in total after exclusion). After each scanning session, a battery of memory tests was performed using a tablet-based screening tool, including free verbal memory, overall verbal memory, episodic memory, orientation, forward digit span, and backward digit span. Using structural MRI and neurite orientation dispersion and density imaging (NODDI) derived from diffusion-weighted images, the authors estimated lesion overlap and neurite density, respectively, with brain networks derived from normative data in healthy participants (somatomotor, dorsal attention, ventral attention, frontoparietal, and default mode network [DMN]). Linear mixed-effect models (LMMs) that regressed out the effect of age, gender, tumor grade, type of treatment, total lesion volume, and total neurite density were used to test the potential longitudinal associations between imaging markers and memory recovery. RESULTS: Memory recovery was not significantly associated with either the tumor location based on traditional lobe classification or the type of treatment received by patients (i.e., surgery alone or surgery with adjuvant chemoradiotherapy). Nonlocal effects of tumors were evident on neurite density, which was reduced not only within the tumor but also beyond the tumor boundary. In contrast, high preoperative neurite density outside the tumor but within the DMN was associated with better memory recovery (LMM, p value after false discovery rate correction [Pfdr] < 10-3). Furthermore, postoperative and follow-up neurite density within the DMN and frontoparietal network were also associated with memory recovery (LMM, Pfdr = 0.014 and Pfdr = 0.001, respectively). Preoperative tumor and postoperative lesion overlap with the DMN showed a significant negative association with memory recovery (LMM, Pfdr = 0.002 and Pfdr < 10-4, respectively). CONCLUSIONS: Imaging biomarkers of cognitive recovery and decline can be identified using NODDI and resting-state networks. Brain tumors and their corresponding treatment affecting brain networks that are fundamental for memory functioning such as the DMN can have a major impact on patients' memory recovery.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Romero-Garcia R, Suckling J, Owen M, et al. Memory recovery in relation to default mode network impairment and neurite density during brain tumor treatment. J Neurosurg. 2021. PMID: 34359041. doi:10.3171/2021.1.JNS203959

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。